NICO.LAB announces new partnership with AI Advance for stroke care
Share
NICO.LAB and AI Advance announced a new partnership that will revolutionise stroke care across Australia and New Zealand. AI Advance will be distributing StrokeViewer, an artificial intelligence solution that empowers physicians with the triaging, diagnosis and treatment decision making of patients in the emergency stroke setting.
StrokeViewer is a clinical decision support tool that combines artificial intelligence (AI) algorithms and a communication platform to help stroke experts make faster well-informed treatment decisions. StrokeViewer allows physicians to diagnose stroke patients remotely, on any mobile or desktop device. The secure cloud-based infrastructure of the solution makes implementation straightforward, requiring no additional hardware. Hospitals across Australia and New Zealand, including those with minimal infrastructure, can implement StrokeViewer and raise their standard of stroke care.
“AI Advance brings a long experience in the medical field and large network to the table, enabling NICO.LAB to hit the ground running in Australia and New Zealand. Their focus on AI solutions, makes them the right partner for us and for the hospitals and clinics in Australia and New Zealand.” says Jeroen Pex, Chief Commercial Officer at NICO.LAB
“I am really excited to bring StrokeViewer to the Australian market. As a country, we are leading with mobile stroke treatment which is attracting government investment to reduce the time to treatment of stroke patients. I am proud that StrokeViewer can further support this strategy.” says Peter Rady, Director and Co-Founder of AI Advance (Australia)
Stroke is a time-critical disease and the third-biggest killer worldwide. During a stroke, two million brain cells die every minute until blood flow is restored [1] therefore starting treatment earlier can make the difference between recovery or life-long disability. In Australia, every 19 minutes a patient suffers from a stroke. There are an estimated 450,000 stroke survivors living in the community, needing daily care[2]. Over half of all survivors need some form of care. Besides the devastating effects on people’s lives, the economic burden in Australia in 2020 was over $6.2 billion[2].
The TGA and Medsafe cleared algorithms are embedded in a cloud-based infrastructure. Medical specialists are notified of the AI results on their smartphone within minutes of the patient being scanned. The physicians are then able to inspect the CT images via a certified diagnostic viewer and diagnose a patient remotely or at the hospital.
